Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 31752-99-5 | MDL No. : | MFCD00078077 |
Formula : | C21H20O5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SZJVIFMPKWMGSX-AKHDSKFASA-N |
M.W : | 352.38 | Pubchem ID : | 2724295 |
Synonyms : |
|
Num. heavy atoms : | 26 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 95.03 |
TPSA : | 72.83 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.26 cm/s |
Log Po/w (iLOGP) : | 2.78 |
Log Po/w (XLOGP3) : | 3.09 |
Log Po/w (WLOGP) : | 2.82 |
Log Po/w (MLOGP) : | 2.86 |
Log Po/w (SILICOS-IT) : | 3.21 |
Consensus Log Po/w : | 2.95 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.98 |
Solubility : | 0.0366 mg/ml ; 0.000104 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.29 |
Solubility : | 0.0182 mg/ml ; 0.0000516 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.04 |
Solubility : | 0.00323 mg/ml ; 0.00000916 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.96 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87.3% | With 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl; trichloroisocyanuric acid; In dichloromethane; at 0℃; for 1h; | (3aR,4S,5R,6aS)-(-)-hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta[b]furan-5-1,1'-biphenyl-4-formate (35.5 g, 0.1 mol), TEMPO-OH (0.81 g, 0.005 mol) was dissolved in 200 mL of dichloromethane,TCCA (25.6g, 0.11mol) was added in batches at 0 C. After the addition,Reaction at 0 C for 1 hour, monitored by TLC. After the reaction, 200 mL of water was added and mixed.The organic phase was then separated, and the aqueous phase was extracted twice with dichloromethane (200 mL * 2).Combine the organic phase separated after the reaction and the organic phase obtained after extraction with the aqueous phase,The combined organic phases were dried over anhydrous sodium sulfate, filtered,The solvent was spin-dried under reduced pressure to give the target product (3aR,4R,5R,6aS)-4-aldehyde hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-formate 29.1g, The yield was 87.3% and the purity was 98.3%. |
With phosphoric acid; dimethyl sulfoxide; dicyclohexyl-carbodiimide; In 1,2-dimethoxyethane; | Compound 1 was synthesized from Corey's lactone 4. The primary alcohol of lactone 4 was oxidized to aldehyde 5 with DCC, DMSO and H3PO4 in DME. The crude aldehyde 5 was reacted with dimethyl (2-oxo-4-phenylbutyl) phosphonate in the presence of lithium chloride and diisopropyl ethyl amine to give 6 in 70% yield. Stereoselective reduction of the enone 6 with S-Alphine hydride in THF at -78 C. provided 70-75% of the (15S)-7 isomer over the (15R)-7 isomer. Alternatively, the reduction could be performed with NaBH4.CeCl4(H2O)7 in MeOH/CH2Cl2 with lower selectivity. The epimers were readily separated by column chromatography on silica gel using tolene:ethyl acetate 2:1 as eluent to give pure (15-S)-7. Removal of the p-phenylbenzoyl (PPB) protective group with K2CO3 in MeOH afforded an 80% yield of the diol 8. The product 8 was purified by column chromatography on silica gel using ethyl acetate as eluent. The free hydroxyl groups of 8 were protected with tetrahydropyranyl (THP) groups to give 9 in quantitative yield. Compound 9 was treated with diisobutylaluminium hydride (DIBAL-H) in dry THF to give the lactol 10. Product 10 underwent Wittig reaction with 4-carboxybutyl-triphenylphosphonium bromide, t-BuOK in dry THF affording the acid 11. This was further reacted without isolation with isopropyl iodide in the presence of DBU in acetone to give the corresponding ester 12, which was isolated by column chromatography on silica gel using ethyl acetate:hexane 1:1. Compound 12 was oxidized with pyridinium chlorchromate treated with aluminium oxide (PCC/Al2O3) in dichloromethane to give the compound 13. The protecting groups 11, 15-bistetrahydro-pyranyloxy groups were removed by addition of 1N HCl in acetonitrile. The reaction mixture was stirred at room temperature for about 3 hrs to give 14. This was further reacted without isolation with addition of excess 1N HCl. The mixture was stirred for additional 40 hrs to accomplish quantitative conversion to the corresponding PGA2 ester analogue (1). | |
With sodium hypochlorite; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium hydrogencarbonate; sodium bromide; In dichloromethane; water; isopropyl alcohol; at -5 - 0℃; for 0.5h; | Example 1 (3aR,4R,5R,6aS)-4-(3-Oxo-5-phenyl-1E-pentenyl)-5-(4-phenylbenzoyloxy)-hexahydro-2H-cyclopenta[b]furan-2-one A solution of <strong>[31752-99-5](-)-Corey lactone 5-(4-phenylbenzoate)</strong> 9 (17.6 g, 50.0 mmol) and TEMPO (0.16 g, 1.0 mmol) in CH2Cl2 (100 mL) was added to a solution of NaBr (0.5 g, 5.0 mmol), NaHCO3 (12.6 g, 150.0 mmol) and IPA (6.0 g, 100.0 mmol) in water (100 mL). 5% aq. NaOCl (about 150 mL) was added dropwise to the stirred mixture at -5 to 0 C. until disappearance of Corey lactone (TLC monitoring). The obtained mixture was stirred for 0.5 h at the same temperature. The aqueous layer was separated and extracted with CH2Cl2 (50 mL). The combined organic layers was added dropwise over 1 h to a stirred mixture of a solution of BnCH2COCH2PO(OMe)2 (15.4 g, 60.0 mmol) in CH2Cl2 (20 mL) and 30% NaOH (8.0 g, 60.0 mmol) at 0-5 C. The mixture was stirred 0.5 h at the same temperature and treated with 10% aq. citric acid (100 mL). The aqueous layer was separated and extracted with CH2Cl2 (50 mL). The combined organic layers were dried over Na2SO4, filtered through short silica gel column and concentrated in vacuo. The oily residue (24.2 g) was dissolved in refluxed EtOH (150 mL) and cooled in ice bath. The precipitate was filtered off, washed with cold EtOH and dried in vacuo to give 20.1 g (84%) of ketone 7 with 99.4% purity by HPLC: mp 129-130 C., [alpha]20D-142 (c 1.0, CHCl3); 1H NMR (CDCl3) 2.32-2.63 (m, 3H); 2.84-2.97 (m, 7H); 5.00-5.10 (m, 1H); 5.20-5.35 (m, 1H); 6.20 (d, J=16 Hz, 1H); 6.65 (dd, J=16 and 8 Hz, 1H); 7.15-7.67 (m, 12H); 8.03 (d, J=8 Hz, 2H). |
Part-B): Preparation of Corey aldehyde from Corey lactone.Dimethoxy ethane (60ml) was charged into Corey lactone (10 g) at 25 to 30c in a 250 ml four neck round bottom flask equipped with mechanical stirrer and dropping funnel. The suspension was stirred for 10 minutes, charged dicyclohexyl carbodiimide (23.3) and dimethyl sulfoxide (DMSO) (17.75 g) at 25 to 300C. The reaction mass was cooled to 20 to 220C and phosphoric acid was added (1.65g). The reaction mixture was maintained at 20 to 22 C for about 20 to 30 minutes. The temperature was raised to 25 to 300C. After completion of reaction, the unwanted dicyclohexyl urea was filtered and washed with dimethoxy ethane (20 ml). The filtrate contains Corey aldehyde. | ||
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; trichloroisocyanuric acid; potassium acetate; In dichloromethane; at -5 - 17℃; for 1.09167h; | Step C: Preparation of (3af?,4f?,5f?,6aS)-4-formyl-2-oxohexahvdro-2/-/- cvclopenta[fc>1furan-5-yl biphenyl-4-carboxylate ((-)-Corev aldehyde, PPB-protected) from (3af?,4S,5/:?,6aS)-4-(hvdroxymethyl)-2-oxohexahvdro-2/-/-cvclopenta[irj1furan-5-yl biphenyl-4-carboxylate ((-)-Corev alcohol, PPB-protected). g 4 parts ry ngTo a 20-L jacketed reactor fitted with a mechanical stirrer and a thermocouple was charged the (-)-Corey alcohol, PPB-protected (250 g, 0.71 mol, 1 molar equivalent), trichloroisocyanuric acid (66 g, 0.29 mol, 0.4 molar equivalent), potassium acetate (166.9 g, 1 .74 mol, 2.4 molar equivalents), and dichloromethane (8000 mL). The mixture was stirred and cooled to -5 C with a circulator. Once the mixture was at the desired temperature, a solution consisting of 2,2,6,6-tetramethyl- piperidin-1 -oxyl (TEMPO, 1 .13 g, 7 mmol, 0.01 molar equivalent) dissolved in dichloromethane (3 mL) was added in one portion via pipet. The mixture changed from white to a light orange within 30 seconds. The internal temperature rose to 17 C within 5 minutes. The circulator was adjusted to 3 C and the mixture was stirred for one hour. After about 15 minutes of stirring, the light orange color turned to white and the internal temperature started to gradually cool to 3 C. The resulting white slurry was treated (strongly effervesces.) with aqueous 5% w/w potassium bicarbonate (5000 mL). The resulting white reaction mixture was filtered through a coarse porosity (40-60 muiotaeta) glass fritted funnel. The filtration could be quite slow. The reactor was rinsed with dichloromethane (1000 mL). The rinse was passed through the filter. The layers of the resulting biphasic filtrate were separated and the lower dichloromethane layer was washed with 10% w/w aqueous potassium iodide (2500 mL), 10% w/w aqueous sodium thiosulfate (2500 mL), and 10% w/w potassium dihydrogenphosphate (2500 mL). The lower dichloromethane layer was dried over magnesium sulfate (500 g). The solids were filtered and the title intermediate was carried onto the next step as the filtrate solution. | |
With phosphoric acid; dimethyl sulfoxide; diisopropyl-carbodiimide; In toluene; at 50℃;Inert atmosphere; Large scale; | 1. Construction of the lower chain (Oxidation and HWE reaction) Preparation of the [l,l'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-2- [( 1 E)-3 -oxo-4-[3 -(trifluoromethyl)phenoxy] - 1 -buten- 1 -yl] -2H-cyclopenta[b] furan-5 -yl /compound of formula (II)/ C2iH2o05 C3iH25F306 Mr: 352.39 Mr: 550.54 1069 g of PPB-Corey-lactone is suspended in an inert atmosphere in 1 1.1 L of water- free toluene. To this suspension are added 1.4 L of diisopropylcarbodiimide and then 0.855 L of dimethyl sulfoxide in phosphoric acid. The reaction mixture is heated to 50C and a further 0.34 L of dimethyl sulfoxide in phosphoric acid is added in portions. After the accomplishment of the oxidation reaction, the mixture is cooled to-10C and while that temperature is maintained, 316 g of potassium hydroxide followed by 1.45 kg of Travoprost phosphonate in toluene solution are added. When the HWE reaction has completed, the reaction mixture is poured onto 1 M hydrochloric acid solution and the mixture is stirred. The precipitated crystals are filtered off and washed. The phases of the filtrate are separated, the organic phase is washed with 1M sodium hydrogen carbonate solution and then with diluted hydrochloric acid solution. The organic phase is evaporated and purified by chromatography on a silica gel column (eluent: toluene - ethyl acetate mixture). The main fraction is evaporated and crystallized from ethyl acetate - hexane mixture. Yield: 915 g, 55 %. Melting point: 112.5-1 14.5C IR spectrum of Travoprost 1. intermediate is shown on Figure 2. Travo rost 1. intermediate , l3C and 19F NMR data: Travoprost 1. intermediate (enone - Formula (II)): 2 118.75 7.20** 1 m (dd) 3 123.95 (q) - - - 'JC-23,F _ 272.5 -61.10 3-F - - - (s, 3) 4 164.94 - - - 5 128.16 - - - 6, 26' 129.95 8.015 2 m J26,27=8.5; 7, 27' 126.87 7.81 2 m 8 144.93 - - -9 138.77 - - -0, 30' 127.01 7.74 2 m (dd) 1, 31 ' 129.10 7 5 1 * * * 2 m (t) 2 128.46 7.43 1 m (tt) ,32~1·6 *, **, ***: Overlapping H NMR signals | |
With Dess-Martin periodane; In dichloromethane; at 5 - 20℃; | a) Dess martin (132.36 g, 1.1 eq) was added to a solution of Corey's lactone (100 g, 1 eq) in DCM (1500 ml) at 5-10C. The mixture was stirred for 1-2 hrs at 15-20C. The solution was filtered and washed with DCM. DCM layer was washed with solution of sodium thiosulfate and sodium bicarbonate in DM water followed by washing with 10% NaCl solution. | |
With Dess-Martin periodane; In dichloromethane; at 22℃; for 0.12h; | Dess-Martin reagent (86.66 g, 1.2 eq) was added in one portion to a 2L three-necked flask containing DCM (480 mL), mechanical stirring was started, and stirring was performed for 10 minutes to give a white cloudy solution.The ice water bath was allowed to cool for 30 min, and a solution of the compound of formula 1 (60.00 g) in DCM (240 mL) was added dropwise to the three-necked vial in about 30 min at 22C. After the medium-term addition, it is partially dissolved.Late turbidity slowly increased. After dripping, warm up naturally and stir for 12 hours.The ice water bath was cooled to 0-5 C and diluted with 600 mL of DCM. The prepared Na2S2O3 aqueous solution (consisting of Na2S2O3161.5 g, 2.6 eq and water 600 mL) was added dropwise.Keep stirring for 2h until the system is clear. Dispense liquid, combine organic phase, cool to 0-2C,A solution consisting of NaHCO3 (26 g) and water (120 mL) was added dropwise.Adjust pH=8, stir for 15 min, and let stand for 15 min. Phase,The organic phase was stirred with acetic acid (160 mg, 10 drops) and acidified to pH=5-6. The product had an HPLC purity of 86% and the product went directly to the next step. |
Tags: 31752-99-5 synthesis path| 31752-99-5 SDS| 31752-99-5 COA| 31752-99-5 purity| 31752-99-5 application| 31752-99-5 NMR| 31752-99-5 COA| 31752-99-5 structure
[ 53275-53-9 ]
(3AS,4R,5S,6aR)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.96
[ 114826-79-8 ]
(3aS,4R,5S,6aR)-5-(Benzyloxy)-4-((benzyloxy)methyl)hexahydro-2H-cyclopenta[b]furan-2-one
Similarity: 0.90
[ 40834-86-4 ]
(3aR,4R,5R,6aS)-2-Oxo-4-((E)-3-oxooct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
[ 40834-88-6 ]
(3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
[ 53275-53-9 ]
(3AS,4R,5S,6aR)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.96
[ 40834-88-6 ]
(3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
[ 128095-32-9 ]
trans-benzyl 3-hydroxycyclopentanecarboxylate
Similarity: 0.82
[ 552849-32-8 ]
Benzyl cis-3-hydroxycyclobutanecarboxylate
Similarity: 0.79
[ 128041-58-7 ]
Benzyl trans-3-hydroxycyclobutanecarboxylate
Similarity: 0.79
[ 53275-53-9 ]
(3AS,4R,5S,6aR)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.96
[ 114826-79-8 ]
(3aS,4R,5S,6aR)-5-(Benzyloxy)-4-((benzyloxy)methyl)hexahydro-2H-cyclopenta[b]furan-2-one
Similarity: 0.90
[ 40834-86-4 ]
(3aR,4R,5R,6aS)-2-Oxo-4-((E)-3-oxooct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
[ 40834-88-6 ]
(3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
[ 53275-53-9 ]
(3AS,4R,5S,6aR)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.96
[ 114826-79-8 ]
(3aS,4R,5S,6aR)-5-(Benzyloxy)-4-((benzyloxy)methyl)hexahydro-2H-cyclopenta[b]furan-2-one
Similarity: 0.90
[ 40834-86-4 ]
(3aR,4R,5R,6aS)-2-Oxo-4-((E)-3-oxooct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
[ 40834-88-6 ]
(3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Similarity: 0.83
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :